6951 - 6975 of 7877 Results
Title
Year
-
RESTRICTEDTitle: Treating Parkinson's disease in the 21st century: Can stem cell transplantation compete?Journal Name: Journal of Comparative NeurologyPublisher: WileyVol: 522Issue #: 12Start Page: 2802End Page: 2816Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/cne.23577Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cne.23577Citation Count: 46
- Large-scale resting state network correlates of cognitive impairment in Parkinson's disease and related dopaminergic deficits2014OPENTitle: Large-scale resting state network correlates of cognitive impairment in Parkinson's disease and related dopaminergic deficitsJournal Name: Frontiers in Systems NeurosciencePublisher: Frontiers Media SAVol: 8Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnsys.2014.00045Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnsys.2014.00045/pdfCitation Count: 96
- Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's disease2014OPENTitle: Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 35Issue #: 10Start Page: 2329End Page: 2346Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.03.032Best OA location URL: https://europepmc.org/articles/pmc4892899?pdf=renderCitation Count: 63
- Accelerating Drug Development for the Field: Building Clinical Trial Recruitment Infrastructure in Parkinson’s2014RESTRICTEDTitle: Accelerating Drug Development for the Field: Building Clinical Trial Recruitment Infrastructure in Parkinson’sJournal Name:Publisher:Vol:Issue #:Start Page: 22End Page: 27Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.14524/cr-13-00066r1.1Citation Count: 1
- Can Isolated Enlarged Virchow-Robin Spaces Influence the Clinical Manifestations of Parkinson's Disease?2014OPENTitle: Can Isolated Enlarged Virchow-Robin Spaces Influence the Clinical Manifestations of Parkinson's Disease?Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 1Issue #: 1Start Page: 67End Page: 69Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12009Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12009Citation Count: 15
- Enhanced ubiquitin-dependent degradation by Nedd4 protects against α-synuclein accumulation and toxicity in animal models of Parkinson's disease2014OPENTitle: Enhanced ubiquitin-dependent degradation by Nedd4 protects against α-synuclein accumulation and toxicity in animal models of Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 64Issue #:Start Page: 79End Page: 87Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2013.12.011Best OA location URL: https://doi.org/10.1016/j.nbd.2013.12.011Citation Count: 72
-
RESTRICTEDTitle: Tau acts as a mediator for Alzheimer's disease‐related synaptic deficitsJournal Name: European Journal of NeurosciencePublisher: WileyVol: 39Issue #: 7Start Page: 1202End Page: 1213Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ejn.12504Best OA location URL: https://europepmc.org/articles/pmc3983570?pdf=renderCitation Count: 44
- Tau phosphorylation and tau mislocalization mediate soluble Aβ oligomer‐induced AMPA glutamate receptor signaling deficits2014OPENTitle: Tau phosphorylation and tau mislocalization mediate soluble Aβ oligomer‐induced AMPA glutamate receptor signaling deficitsJournal Name: European Journal of NeurosciencePublisher: WileyVol: 39Issue #: 7Start Page: 1214End Page: 1224Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ejn.12507Best OA location URL: https://europepmc.org/articles/pmc4123852?pdf=renderCitation Count: 117
-
OPENTitle: Tremor in Spinocerebellar Ataxia Type 12Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 1Issue #: 1Start Page: 76End Page: 78Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12015Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12015Citation Count: 9
-
OPENTitle: Association Studies of Sporadic Parkinson’s Disease in the Genomic EraJournal Name: Current GenomicsPublisher: Bentham Science Publishers Ltd.Vol: 15Issue #: 1Start Page: 2End Page: 10Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2174/1389202914666131210212745Best OA location URL: https://europepmc.org/articles/pmc3958956?pdf=renderCitation Count: 22
-
OPENTitle: Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's DiseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 6Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2014.00053Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2014.00053/pdfCitation Count: 144
-
OPENTitle: Barriers to investigator-initiated deep brain stimulation and device researchJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 82Issue #: 16Start Page: 1465End Page: 1473Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000000345Best OA location URL: https://europepmc.org/articles/pmc4001198?pdf=renderCitation Count: 17
-
OPENTitle: Membrane recruitment of endogenous LRRK2 precedes its potent regulation of autophagyJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 23Issue #: 16Start Page: 4201End Page: 4214Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/hmg/ddu138Best OA location URL: https://academic.oup.com/hmg/article-pdf/23/16/4201/1737006/ddu138.pdfCitation Count: 209
-
OPENTitle: Parkin is activated by PINK1-dependent phosphorylation of ubiquitin at Ser65Journal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 460Issue #: 1Start Page: 127End Page: 141Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1042/bj20140334Best OA location URL: https://portlandpress.com/biochemj/article-pdf/460/1/127/678769/bj4600127.pdfCitation Count: 728
- Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivo2014OPENTitle: Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivoJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 137Issue #: 5Start Page: 1496End Page: 1513Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awu057Best OA location URL: https://academic.oup.com/brain/article-pdf/137/5/1496/11140606/awu057.pdfCitation Count: 200
-
OPENTitle: Tremor retrainment as therapeutic strategy in psychogenic (functional) tremorJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 20Issue #: 6Start Page: 647End Page: 650Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2014.02.029Best OA location URL: https://europepmc.org/articles/pmc4028378?pdf=renderCitation Count: 41
-
OPENTitle: EIF4G1 gene mutations are not a common cause of Parkinson's disease in the Japanese populationJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 20Issue #: 6Start Page: 659End Page: 661Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2014.03.004Best OA location URL: https://europepmc.org/articles/pmc4034257?pdf=renderCitation Count: 15
-
OPENTitle: Swallowing Outcomes Following Unilateral STN vs. GPi Surgery: A Retrospective AnalysisJournal Name: DysphagiaPublisher: Springer Science and Business Media LLCVol: 29Issue #: 4Start Page: 425End Page: 431Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00455-014-9522-0Best OA location URL: https://europepmc.org/articles/pmc4127154?pdf=renderCitation Count: 42
-
RESTRICTEDTitle: Fox Trial Finder, un nouvel outil pour la recherche cliniqueJournal Name: Revue NeurologiquePublisher: Elsevier BVVol: 170Issue #:Start Page: A133End Page: A134Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurol.2014.01.360Citation Count: 0
-
OPENTitle: Identifying blood-brain-barrier selective single-chain antibody fragmentsJournal Name: Biotechnology JournalPublisher: WileyVol: 9Issue #: 5Start Page: 664End Page: 674Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/biot.201300550Best OA location URL: https://europepmc.org/articles/pmc4073886?pdf=renderCitation Count: 22
-
OPENTitle: Radiosynthesis and in Vivo Evaluation of Two PET Radioligands for Imaging α-SynucleinJournal Name: Applied SciencesPublisher: MDPI AGVol: 4Issue #: 1Start Page: 66End Page: 78Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/app4010066Best OA location URL: https://www.mdpi.com/2076-3417/4/1/66/pdf?version=1395063831Citation Count: 52
- Differential LRRK2 expression in the cortex, striatum, and substantia nigra in transgenic and nontransgenic rodents2014OPENTitle: Differential LRRK2 expression in the cortex, striatum, and substantia nigra in transgenic and nontransgenic rodentsJournal Name: Journal of Comparative NeurologyPublisher: WileyVol: 522Issue #: 11Start Page: 2465End Page: 2480Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/cne.23583Best OA location URL: https://europepmc.org/articles/pmc4076169?pdf=renderCitation Count: 117
- Measuring the Lifespace of People With Parkinson’s Disease Using Smartphones: Proof of Principle2014OPENTitle: Measuring the Lifespace of People With Parkinson’s Disease Using Smartphones: Proof of PrincipleJournal Name: JMIR mhealth and uhealthPublisher: JMIR Publications Inc.Vol: 2Issue #: 1Start Page: e13End Page: e13Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.2196/mhealth.2799Best OA location URL: https://mhealth.jmir.org/2014/1/e13/PDFCitation Count: 84
- Cerebrospinal Fluid α-Synuclein Predicts Cognitive Decline in Parkinson Disease Progression in the DATATOP Cohort2014OPENTitle: Cerebrospinal Fluid α-Synuclein Predicts Cognitive Decline in Parkinson Disease Progression in the DATATOP CohortJournal Name: The American Journal of PathologyPublisher: Elsevier BVVol: 184Issue #: 4Start Page: 966End Page: 975Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ajpath.2013.12.007Best OA location URL: http://ajp.amjpathol.org/article/S0002944014000121/pdfCitation Count: 125
- Combined fenobam and amantadine treatment promotes robust antidyskinetic effects in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐lesioned primate model of Parkinson's disease2014RESTRICTEDTitle: Combined fenobam and amantadine treatment promotes robust antidyskinetic effects in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐lesioned primate model of Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 29Issue #: 6Start Page: 772End Page: 779Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.25859Citation Count: 38